查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1883030

生物防禦市場規模、佔有率、成長及全球產業分析：按類型、應用和地區劃分的洞察與預測（2024-2032 年）

Biodefense Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 200 Pages | 商品交期: 請詢問到貨日

價格

生物防禦市場成長驅動因素

隨著世界各國面臨日益嚴重的生物威脅、對生物恐怖主義的擔憂日益加劇以及傳染病疫情頻繁，全球生物防禦市場持續擴張。根據最新評估，生物防禦市場預計將在 2024 年達到 153.9 億美元，並在 2025 年增長至 162.3 億美元。預計到 2032 年，該市場將飆升至 246.4 億美元，預測期內複合年增長率 (CAGR) 為 6.1%。北美地區在先進的基礎設施、強有力的政府計劃和穩健的公私合作關係的推動下，於 2024 年以 42.88% 的市場佔有率引領市場。

生物防禦是一個涵蓋生物威脅（無論是自然發生的、意外的還是人為造成的）的檢測、預防和緩解的統稱概念。從軍事準備到民用保護，生物防禦系統包括生物監測、診斷工具、疫苗、消毒技術和緊急應變能力。日益加劇的地緣政治緊張局勢，例如俄烏衝突，進一步凸顯了全球生物防禦準備工作的迫切性。

市場驅動因素

市場成長的關鍵驅動因素是全球對生物風險日益增強的認識。流行病和反覆出現的傳染病、合成生物學的進步以及高風險生物工程技術的發展，正迫使各國政府增加生物防禦預算。製藥和生物技術公司正在加速疫苗研發、診斷創新和治療研究，以加強國家安全。

世界各國政府都在大力投資生物防禦基礎設施。值得注意的是，2025年4月，帕森斯公司從美國海軍醫學研究司令部獲得了一份價值2400萬美元的合同，用於開發傳染病檢測技術。人工智慧、機器學習、生物感測器和物聯網系統的創新正在透過提高監測效率和實現即時威脅分析來變革生物防禦。

市場限制因子

儘管發展勢頭強勁，但市場仍面臨諸多挑戰，例如研發成本高昂、審批流程漫長以及商業可行性的不確定性。許多生物防禦產品針對的是罕見病原體，缺乏真實世界疫情數據，這使得企業難以進行大規模測試。

此外，由於缺乏政府採購計畫的保障，研發投資的回收存在不確定性。責任問題、嚴格的監管流程和嚴格的生物安全法規也限制了市場准入，尤其是對於中小型生物技術公司而言。

市場機會

新冠肺炎、伊波拉和猴痘等傳染病疫情的增加，凸顯了快速反應疫苗、治療方法和先進生物監測系統的必要性。這為技術開發人員創造了新的機遇，尤其是在基因組學、基於人工智慧的威脅預測和便攜式檢測系統等領域。

加強政府、生技公司和研究機構之間的合作，正在增強能力建設。預計未來十年，全球向數位化生物安全、預警系統和下一代生物感測器的轉型將為產業參與者創造重大機會。

市場趨勢

影響市場的關鍵趨勢是先進監測和消毒技術的日益普及。 2024年，紫外線 (UV) 系統因其高效的微生物滅活效果和對快速消毒工具的強勁需求，在技術方面引領市場。生物感測器預計將成為成長最快的系統領域，能夠在軍事、邊境管制和臨床應用中實現精準、即時的威脅偵測。

合成生物學、快速診斷、基因組學和載體疫苗等領域的技術進步也在革新生物防禦。 2022年2月，Tesseragen Biotechnology與Biomade合作，增強其人工智慧驅動的發酵生物製造平台。這顯示生物技術和人工智慧在生物防禦領域的融合日益加深。

細分市場概覽

依技術劃分：

紫外線技術將在2024年佔主導地位，並由於消毒需求旺盛，將繼續保持成長最快的技術地位。伽瑪射線、冷等離子體和微波加熱技術的應用也不斷擴展，尤其是在滅菌和去污領域。

依系統劃分：

受生物恐怖主義和傳染病爆發日益增長的擔憂推動，生物危害檢測系統在2024年佔了最大的市場佔有率。由於生物感測器的快速小型化和現場可用性的提高，預計生物感測器將在2025年至2032年間實現最快成長。

最終用戶：

軍事組織將在2024年佔最大的市場佔有率，這反映了全球安全問題的日益關注。由於對疫苗和治療藥物的投資增加，製藥和生物技術公司預計將成為成長最快的領域。

區域洞察

北美將在2024年繼續保持最大的區域市場地位，達到66億美元，這得益於“生物盾牌計劃”（Project Bioshield）和“生物醫學高級研究與發展局”（BARDA）等項目的支持。美國國立衛生研究院 (NIH)、疾病管制與預防中心 (CDC) 和國防部 (DoD) 的頻繁投資（例如，SIGA Technologies 於 2024 年與國防部簽訂的 TPOXX 合約）持續鞏固了其在該地區的市場領導地位。

歐洲預計將成為成長最快的地區，這得益於政府的大力資助、HERA 計劃以及重大合同，例如 Smiths Detection 與國防部簽訂的價值 8960 萬美元的化學威脅檢測合同。

在亞太地區，疾病爆發的增加、軍事現代化以及生物監測投資的擴大，正在創造豐厚的市場機會。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：主要發現

  • 主要行業趨勢 - 主要合約和協議、併購和合作
  • 最新技術進展
  • 波特五力分析
  • 供應鏈分析
  • 定性分析 - COVID-19 疫情對全球生物防禦市場的影響
  • 全球生物防禦市場監理分析市場

第五章：全球生物防禦市場分析、洞察與預測（2019-2032）

  • 主要發現/定義
  • 市場分析、洞察與預測 - 按技術分類
    • 微波加熱
    • 紫外線
    • 伽瑪射線輻照
    • 冷等離子體
    • 其他
  • 市場分析、洞察與預測 - 按系統分類
    • 數位生物監測網絡
    • 早期預警系統
    • 生物危害檢測系統
    • 人工智慧輔助監測系統
    • 生物感測器
    • 其他
  • 市場分析、洞察與預測 - 按最終用戶分類
    • 軍事
    • 國土安全部
    • 醫院及診所
    • 製藥和生技公司
    • 病毒學實驗室
  • 市場分析、洞察與預測 - 按地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 拉丁美洲

第六章：北美生物防禦市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲生物防禦市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 美國王國
    • 德國
    • 法國
    • 俄羅斯
    • 歐洲其他地區

第八章 亞太生物防禦市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區

第九章 中東與非洲生物防禦市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 土耳其
    • 中東和非洲其他地區

第十章拉丁美洲生物防禦市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家

第11章：競爭分析

  • 全球市場排名分析（2024）
  • 競爭格局概覽

第12章：公司簡介

  • AirBoss Defense Group, Inc.（美國）
  • Bioquell，藝康集團旗下公司（美國）
  • Bio-Rad Laboratories, Inc.（美國）
  • BlueDot Inc.（加拿大）
  • E4life Srl （澳洲）
  • Emergent BioSolutions Inc.（美國）
  • SIGA Technologies, Inc.（美國）
  • Dynavax Technologies（美國）
  • Alnylam Pharmaceuticals, Inc.（美國）
  • Ichor Medical Systems Inc.（美國）
  • Bavarian Nordic A/S（丹麥）
  • SKAN AG（瑞士）
  • Smiths Detection Group Ltd（英國）
  • Parsons Corporation（美國）
Product Code: FBI113684

Growth Factors of biodefense Market

The global biodefense market continues to expand as nations worldwide confront escalating biological threats, rising bioterrorism concerns, and increasingly frequent infectious disease outbreaks. According to the latest assessment, the biodefense market size reached USD 15.39 billion in 2024, is projected to grow to USD 16.23 billion in 2025, and is expected to further surge to USD 24.64 billion by 2032, reflecting a CAGR of 6.1% during the forecast period. North America dominated the landscape in 2024 with a 42.88% market share, driven by advanced infrastructure, robust government programs, and strong private-public collaborations.

Biodefense encompasses the detection, prevention, and mitigation of biological threats-whether naturally occurring, accidental, or intentional. From military preparedness to civilian protection, biodefense systems involve biosurveillance, diagnostic tools, vaccines, decontamination technology, and emergency response capabilities. Increasing geopolitical tensions, such as those escalated by the Russia-Ukraine conflict, further emphasize the urgency for global biodefense preparedness.

Market Drivers

A key driver behind market growth is the heightened global awareness of biological risks. The recurrence of pandemics and infectious diseases, coupled with advances in synthetic biology and high-risk bioengineering capabilities, has prompted governments to expand biodefense budgets. Pharmaceutical and biotechnology companies are accelerating vaccine development, diagnostics innovation, and therapeutic research to strengthen national security readiness.

Governments worldwide are investing heavily in biodefense infrastructure. Notably, in April 2025, Parsons Corporation secured a USD 24 million U.S. Naval Medical Research Command contract to advance infectious disease detection technologies. Innovations in AI, machine learning, biosensors, and IoT systems are transforming biodefense by improving surveillance efficiency and enabling real-time threat analysis.

Market Restraints

Despite strong momentum, the market faces challenges including high R&D costs, long approval timelines, and uncertainty surrounding commercial viability. Because many biodefense products target rare pathogens with limited real-world outbreak data, companies encounter difficulties in conducting large-scale trials.

Moreover, without guaranteed government procurement programs, recovering development investments becomes uncertain. Liability concerns, highly regulated pathways, and stringent biosafety rules also limit participation-particularly among smaller biotech firms.

Market Opportunities

The rising prevalence of outbreaks such as COVID-19, Ebola, and mpox has underscored the need for rapid-response vaccines, therapeutics, and advanced biosurveillance systems. This is creating new opportunities for technology developers, particularly in genomics, AI-driven threat prediction, and portable detection systems.

Increasing collaboration between governments, biotech firms, and research institutions is strengthening capability-building efforts. The global shift toward digital biosecurity, early warning systems, and next-generation biosensors is expected to be a major opportunity for industry players over the next decade.

Market Trends

A significant trend shaping the market is the growing adoption of advanced surveillance and disinfection technologies. UV light systems led the market by technology in 2024 due to their effectiveness in microbial inactivation and strong demand for rapid sterilization tools. Biosensors are expected to be the fastest-growing system segment, enabling accurate, real-time threat detection across military, border control, and clinical applications.

Breakthroughs in synthetic biology, rapid diagnostics, genomics, and vector-based vaccines are also transforming biodefense preparedness. In February 2022, TeselaGen Biotechnology signed a collaboration with BioMADE to enhance AI-driven fermentation biomanufacturing platforms-highlighting the rising convergence of biotechnology and artificial intelligence in biodefense.

Segmentation Overview

Technology:

UV light dominated in 2024 and remains the fastest-growing technology due to high demand for disinfection. Gamma radiation, cold plasma, and microwave heating are also expanding applications, particularly in sterilization and decontamination.

System:

Biohazard detection systems accounted for the largest share in 2024, driven by rising bioterrorism and outbreak concerns. Biosensors will grow the fastest from 2025-2032 due to rapid miniaturization and field operability.

End User:

Military forces held the largest share in 2024, reflecting heightened global security concerns. Pharmaceutical & biotech companies are expected to be the fastest-growing segment due to increased investment in vaccines and therapeutics.

Regional Insights

North America remained the largest regional market in 2024, valued at USD 6.60 billion, supported by programs such as Project BioShield and BARDA. Frequent investments from NIH, CDC, and the DoD-such as SIGA Technologies' DOD contract for TPOXX in 2024-continue to strengthen the region's market leadership.

Europe is projected to be the fastest-growing region, driven by strong government funding, HERA initiatives, and major contracts such as Smiths Detection's USD 89.6 million MoD award for chemical threat detection.

Asia Pacific presents lucrative opportunities due to rising disease outbreaks, military modernization, and expanded biosurveillance investments.

Conclusion

Given rising biological threats, geopolitical instability, and rapid advances in biotechnology, the biodefense market is set to grow steadily from USD 15.39 billion in 2024 to USD 24.64 billion by 2032. Increasing global funding, technological innovation, and the demand for rapid detection and response systems will play central roles in shaping market evolution.

By Segmentation By Technology

  • UV Light
  • Gamma Radiation
  • Cold Plasma
  • Microwave Heating
  • Others

By System

  • Digital Biosurveillance Networks
  • Early Warning Systems
  • Biohazard Detection Systems
  • AI-Assisted Surveillance System
  • Biosensors
  • Others

By End User

  • Military Forces
  • Homeland Security
  • Hospitals & Clinics
  • Pharmaceutical & Biotech Companies
  • Virological Research Institutes

By Region

  • North America (By Technology, By System, By End User, By Country)
    • U.S. (By End User)
    • Canada (By End User)
  • Europe (By Technology, By System, By End User, By Country)
    • U.K. (By End User)
    • Germany (By End User)
    • France (By End User)
    • Russia (By End User)
    • Rest of Europe (By End User)
  • Asia Pacific (By Technology, By System, By End User, By Country)
    • China (By End User)
    • India (By End User)
    • Japan (By End User)
    • South Korea (By End User)
    • Rest of Asia Pacific (By End User)
  • Middle East & Africa (By Technology, By System, By End User, By Country)
  • Iran (By End User)
    • Israel (By End User)
    • Saudi Arabia (By End User)
    • Turkey (By End User)
    • Rest of Middle East & Africa (By End User)
  • Latin America (By Technology, By System, By End User, By Country)
    • Brazil (By End User)
    • Argentina (By End User)
    • Mexico (By End User)
    • Rest of Latin America (By End User)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Key Industry Developments - Key Contracts & Agreements, Mergers, Acquisitions and Partnerships
  • 4.2. Latest Technological Advancements
  • 4.3. Porters Five Forces Analysis
  • 4.4. Supply Chain Analysis
  • 4.5. Qualitative Insights - Impact of COVID-19 Pandemic on Global Biodefense Market
  • 4.6. Regulatory Analysis on Global Biodefense Market

5. Global Biodefense Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Key Findings / Definition
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Microwave Heating
    • 5.2.2. UV Light
    • 5.2.3. Gamma Radiation
    • 5.2.4. Cold Plasma
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By System
    • 5.3.1. Digital Biosurveillance Networks
    • 5.3.2. Early Warning Systems
    • 5.3.3. Biohazard Detection Systems
    • 5.3.4. AI-Assisted Surveillance System
    • 5.3.5. Biosensors
    • 5.3.6. Others
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Military Forces
    • 5.4.2. Homeland Security
    • 5.4.3. Hospitals & Clinics
    • 5.4.4. Pharmaceutical & Biotech Companies
    • 5.4.5. Virological Research Institutes
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Middle East & Africa
    • 5.5.5. Latin America

6. North America Biodefense Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Technology
    • 6.1.1. Microwave Heating
    • 6.1.2. UV Light
    • 6.1.3. Gamma Radiation
    • 6.1.4. Cold Plasma
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By System
    • 6.2.1. Digital Biosurveillance Networks
    • 6.2.2. Early Warning Systems
    • 6.2.3. Biohazard Detection Systems
    • 6.2.4. AI-Assisted Surveillance System
    • 6.2.5. Biosensors
    • 6.2.6. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Military Forces
    • 6.3.2. Homeland Security
    • 6.3.3. Hospitals & Clinics
    • 6.3.4. Pharmaceutical & Biotech Companies
    • 6.3.5. Virological Research Institutes
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. Market Analysis, Insights and Forecast - By End User
        • 6.4.1.1.1. Military Forces
        • 6.4.1.1.2. Homeland Security
        • 6.4.1.1.3. Hospitals & Clinics
        • 6.4.1.1.4. Pharmaceutical & Biotech Companies
        • 6.4.1.1.5. Virological Research Institutes
    • 6.4.2. Canada
      • 6.4.2.1. Market Analysis, Insights and Forecast - By End User
        • 6.4.2.1.1. Military Forces
        • 6.4.2.1.2. Homeland Security
        • 6.4.2.1.3. Hospitals & Clinics
        • 6.4.2.1.4. Pharmaceutical & Biotech Companies
        • 6.4.2.1.5. Virological Research Institutes

7. Europe Biodefense Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Technology
    • 7.1.1. Microwave Heating
    • 7.1.2. UV Light
    • 7.1.3. Gamma Radiation
    • 7.1.4. Cold Plasma
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By System
    • 7.2.1. Digital Biosurveillance Networks
    • 7.2.2. Early Warning Systems
    • 7.2.3. Biohazard Detection Systems
    • 7.2.4. AI-Assisted Surveillance System
    • 7.2.5. Biosensors
    • 7.2.6. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Military Forces
    • 7.3.2. Homeland Security
    • 7.3.3. Hospitals & Clinics
    • 7.3.4. Pharmaceutical & Biotech Companies
    • 7.3.5. Virological Research Institutes
  • 7.4. Market Analysis, Insights and Forecast - By Country
    • 7.4.1. U.K.
      • 7.4.1.1. Market Analysis, Insights and Forecast - By End User
        • 7.4.1.1.1. Military Forces
        • 7.4.1.1.2. Homeland Security
        • 7.4.1.1.3. Hospitals & Clinics
        • 7.4.1.1.4. Pharmaceutical & Biotech Companies
        • 7.4.1.1.5. Virological Research Institutes
    • 7.4.2. Germany
      • 7.4.2.1. Market Analysis, Insights and Forecast - By End User
        • 7.4.2.1.1. Military Forces
        • 7.4.2.1.2. Homeland Security
        • 7.4.2.1.3. Hospitals & Clinics
        • 7.4.2.1.4. Pharmaceutical & Biotech Companies
        • 7.4.2.1.5. Virological Research Institutes
    • 7.4.3. France
      • 7.4.3.1. Market Analysis, Insights and Forecast - By End User
        • 7.4.3.1.1. Military Forces
        • 7.4.3.1.2. Homeland Security
        • 7.4.3.1.3. Hospitals & Clinics
        • 7.4.3.1.4. Pharmaceutical & Biotech Companies
        • 7.4.3.1.5. Virological Research Institutes
    • 7.4.4. Russia
      • 7.4.4.1. Market Analysis, Insights and Forecast - By End User
        • 7.4.4.1.1. Military Forces
        • 7.4.4.1.2. Homeland Security
        • 7.4.4.1.3. Hospitals & Clinics
        • 7.4.4.1.4. Pharmaceutical & Biotech Companies
        • 7.4.4.1.5. Virological Research Institutes
    • 7.4.5. Rest of Europe
      • 7.4.5.1. Market Analysis, Insights and Forecast - By End User
        • 7.4.5.1.1. Military Forces
        • 7.4.5.1.2. Homeland Security
        • 7.4.5.1.3. Hospitals & Clinics
        • 7.4.5.1.4. Pharmaceutical & Biotech Companies
        • 7.4.5.1.5. Virological Research Institutes

8. Asia Pacific Biodefense Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Technology
    • 8.1.1. Microwave Heating
    • 8.1.2. UV Light
    • 8.1.3. Gamma Radiation
    • 8.1.4. Cold Plasma
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By System
    • 8.2.1. Digital Biosurveillance Networks
    • 8.2.2. Early Warning Systems
    • 8.2.3. Biohazard Detection Systems
    • 8.2.4. AI-Assisted Surveillance System
    • 8.2.5. Biosensors
    • 8.2.6. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Military Forces
    • 8.3.2. Homeland Security
    • 8.3.3. Hospitals & Clinics
    • 8.3.4. Pharmaceutical & Biotech Companies
    • 8.3.5. Virological Research Institutes
  • 8.4. Market Analysis, Insights and Forecast - By Country
    • 8.4.1. China
      • 8.4.1.1. Market Analysis, Insights and Forecast - By End User
        • 8.4.1.1.1. Military Forces
        • 8.4.1.1.2. Homeland Security
        • 8.4.1.1.3. Hospitals & Clinics
        • 8.4.1.1.4. Pharmaceutical & Biotech Companies
        • 8.4.1.1.5. Virological Research Institutes
    • 8.4.2. India
      • 8.4.2.1. Market Analysis, Insights and Forecast - By End User
        • 8.4.2.1.1. Military Forces
        • 8.4.2.1.2. Homeland Security
        • 8.4.2.1.3. Hospitals & Clinics
        • 8.4.2.1.4. Pharmaceutical & Biotech Companies
        • 8.4.2.1.5. Virological Research Institutes
    • 8.4.3. Japan
      • 8.4.3.1. Market Analysis, Insights and Forecast - By End User
        • 8.4.3.1.1. Military Forces
        • 8.4.3.1.2. Homeland Security
        • 8.4.3.1.3. Hospitals & Clinics
        • 8.4.3.1.4. Pharmaceutical & Biotech Companies
        • 8.4.3.1.5. Virological Research Institutes
    • 8.4.4. South Korea
      • 8.4.4.1. Market Analysis, Insights and Forecast - By End User
        • 8.4.4.1.1. Military Forces
        • 8.4.4.1.2. Homeland Security
        • 8.4.4.1.3. Hospitals & Clinics
        • 8.4.4.1.4. Pharmaceutical & Biotech Companies
        • 8.4.4.1.5. Virological Research Institutes
    • 8.4.5. Rest of Asia Pacific
      • 8.4.5.1. Market Analysis, Insights and Forecast - By End User
        • 8.4.5.1.1. Military Forces
        • 8.4.5.1.2. Homeland Security
        • 8.4.5.1.3. Hospitals & Clinics
        • 8.4.5.1.4. Pharmaceutical & Biotech Companies
        • 8.4.5.1.5. Virological Research Institutes

9. Middle East & Africa Biodefense Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Technology
    • 9.1.1. Microwave Heating
    • 9.1.2. UV Light
    • 9.1.3. Gamma Radiation
    • 9.1.4. Cold Plasma
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By System
    • 9.2.1. Digital Biosurveillance Networks
    • 9.2.2. Early Warning Systems
    • 9.2.3. Biohazard Detection Systems
    • 9.2.4. AI-Assisted Surveillance System
    • 9.2.5. Biosensors
    • 9.2.6. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Military Forces
    • 9.3.2. Homeland Security
    • 9.3.3. Hospitals & Clinics
    • 9.3.4. Pharmaceutical & Biotech Companies
    • 9.3.5. Virological Research Institutes
  • 9.4. Market Analysis, Insights and Forecast - By Country
    • 9.4.1. Iran
      • 9.4.1.1. Market Analysis, Insights and Forecast - By End User
        • 9.4.1.1.1. Military Forces
        • 9.4.1.1.2. Homeland Security
        • 9.4.1.1.3. Hospitals & Clinics
        • 9.4.1.1.4. Pharmaceutical & Biotech Companies
        • 9.4.1.1.5. Virological Research Institutes
    • 9.4.2. Israel
      • 9.4.2.1. Market Analysis, Insights and Forecast - By End User
        • 9.4.2.1.1. Military Forces
        • 9.4.2.1.2. Homeland Security
        • 9.4.2.1.3. Hospitals & Clinics
        • 9.4.2.1.4. Pharmaceutical & Biotech Companies
        • 9.4.2.1.5. Virological Research Institutes
    • 9.4.3. Saudi Arabia
      • 9.4.3.1. Market Analysis, Insights and Forecast - By End User
        • 9.4.3.1.1. Military Forces
        • 9.4.3.1.2. Homeland Security
        • 9.4.3.1.3. Hospitals & Clinics
        • 9.4.3.1.4. Pharmaceutical & Biotech Companies
        • 9.4.3.1.5. Virological Research Institutes
    • 9.4.4. Turkey
      • 9.4.4.1. Market Analysis, Insights and Forecast - By End User
        • 9.4.4.1.1. Military Forces
        • 9.4.4.1.2. Homeland Security
        • 9.4.4.1.3. Hospitals & Clinics
        • 9.4.4.1.4. Pharmaceutical & Biotech Companies
        • 9.4.4.1.5. Virological Research Institutes
    • 9.4.5. Rest of Middle East & Africa
      • 9.4.5.1. Market Analysis, Insights and Forecast - By End User
        • 9.4.5.1.1. Military Forces
        • 9.4.5.1.2. Homeland Security
        • 9.4.5.1.3. Hospitals & Clinics
        • 9.4.5.1.4. Pharmaceutical & Biotech Companies
        • 9.4.5.1.5. Virological Research Institutes

10. Latin America Biodefense Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Technology
    • 10.1.1. Microwave Heating
    • 10.1.2. UV Light
    • 10.1.3. Gamma Radiation
    • 10.1.4. Cold Plasma
    • 10.1.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By System
    • 10.2.1. Digital Biosurveillance Networks
    • 10.2.2. Early Warning Systems
    • 10.2.3. Biohazard Detection Systems
    • 10.2.4. AI-Assisted Surveillance System
    • 10.2.5. Biosensors
    • 10.2.6. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Military Forces
    • 10.3.2. Homeland Security
    • 10.3.3. Hospitals & Clinics
    • 10.3.4. Pharmaceutical & Biotech Companies
    • 10.3.5. Virological Research Institutes
  • 10.4. Market Analysis, Insights and Forecast - By Country
    • 10.4.1. Brazil
      • 10.4.1.1. Market Analysis, Insights and Forecast - By End User
        • 10.4.1.1.1. Military Forces
        • 10.4.1.1.2. Homeland Security
        • 10.4.1.1.3. Hospitals & Clinics
        • 10.4.1.1.4. Pharmaceutical & Biotech Companies
        • 10.4.1.1.5. Virological Research Institutes
    • 10.4.2. Argentina
      • 10.4.2.1. Market Analysis, Insights and Forecast - By End User
        • 10.4.2.1.1. Military Forces
        • 10.4.2.1.2. Homeland Security
        • 10.4.2.1.3. Hospitals & Clinics
        • 10.4.2.1.4. Pharmaceutical & Biotech Companies
        • 10.4.2.1.5. Virological Research Institutes
    • 10.4.3. Mexico
      • 10.4.3.1. Market Analysis, Insights and Forecast - By End User
        • 10.4.3.1.1. Military Forces
        • 10.4.3.1.2. Homeland Security
        • 10.4.3.1.3. Hospitals & Clinics
        • 10.4.3.1.4. Pharmaceutical & Biotech Companies
        • 10.4.3.1.5. Virological Research Institutes
    • 10.4.4. Rest of Latin America
      • 10.4.4.1. Market Analysis, Insights and Forecast - By End User
        • 10.4.4.1.1. Military Forces
        • 10.4.4.1.2. Homeland Security
        • 10.4.4.1.3. Hospitals & Clinics
        • 10.4.4.1.4. Pharmaceutical & Biotech Companies
        • 10.4.4.1.5. Virological Research Institutes

11. Competitive Analysis

  • 11.1. Global Market Rank Analysis (2024)
  • 11.2. Competitive Dashboard

12. Company Profiles

  • 12.1. AirBoss Defense Group, Inc. (U.S.)
    • 12.1.1. Overview
    • 12.1.2. Products & services
    • 12.1.3. SWOT Analysis
    • 12.1.4. Recent Developments
    • 12.1.5. Strategies
    • 12.1.6. Financials (Based on Availability)
  • 12.2. Bioquell, An Ecolab Solution (U.S.)
    • 12.2.1. Overview
    • 12.2.2. Products & services
    • 12.2.3. SWOT Analysis
    • 12.2.4. Recent Developments
    • 12.2.5. Strategies
    • 12.2.6. Financials (Based on Availability)
  • 12.3. Bio-Rad Laboratories, Inc. (U.S.)
    • 12.3.1. Overview
    • 12.3.2. Products & services
    • 12.3.3. SWOT Analysis
    • 12.3.4. Recent Developments
    • 12.3.5. Strategies
    • 12.3.6. Financials (Based on Availability)
  • 12.4. BlueDot Inc. (Canada)
    • 12.4.1. Overview
    • 12.4.2. Products & services
    • 12.4.3. SWOT Analysis
    • 12.4.4. Recent Developments
    • 12.4.5. Strategies
    • 12.4.6. Financials (Based on Availability)
  • 12.5. E4life Srl (Australia)
    • 12.5.1. Overview
    • 12.5.2. Products & services
    • 12.5.3. SWOT Analysis
    • 12.5.4. Recent Developments
    • 12.5.5. Strategies
    • 12.5.6. Financials (Based on Availability)
  • 12.6. Emergent BioSolutions Inc. (U.S.)
    • 12.6.1. Overview
    • 12.6.2. Products & services
    • 12.6.3. SWOT Analysis
    • 12.6.4. Recent Developments
    • 12.6.5. Strategies
    • 12.6.6. Financials (Based on Availability)
  • 12.7. SIGA Technologies, Inc. (U.S.)
    • 12.7.1. Overview
    • 12.7.2. Products & services
    • 12.7.3. SWOT Analysis
    • 12.7.4. Recent Developments
    • 12.7.5. Strategies
    • 12.7.6. Financials (Based on Availability)
  • 12.8. Dynavax Technologies (U.S.)
    • 12.8.1. Overview
    • 12.8.2. Products & services
    • 12.8.3. SWOT Analysis
    • 12.8.4. Recent Developments
    • 12.8.5. Strategies
    • 12.8.6. Financials (Based on Availability)
  • 12.9. Alnylam Pharmaceuticals, Inc. (U.S.)
    • 12.9.1. Overview
    • 12.9.2. Products & services
    • 12.9.3. SWOT Analysis
    • 12.9.4. Recent Developments
    • 12.9.5. Strategies
    • 12.9.6. Financials (Based on Availability)
  • 12.10. Ichor Medical Systems Inc. (U.S.)
    • 12.10.1. Overview
    • 12.10.2. Products & services
    • 12.10.3. SWOT Analysis
    • 12.10.4. Recent Developments
    • 12.10.5. Strategies
    • 12.10.6. Financials (Based on Availability)
  • 12.11. Bavarian Nordic A/S (Denmark)
    • 12.11.1. Overview
    • 12.11.2. Products & services
    • 12.11.3. SWOT Analysis
    • 12.11.4. Recent Developments
    • 12.11.5. Strategies
    • 12.11.6. Financials (Based on Availability)
  • 12.12. SKAN AG (Switzerland)
    • 12.12.1. Overview
    • 12.12.2. Products & services
    • 12.12.3. SWOT Analysis
    • 12.12.4. Recent Developments
    • 12.12.5. Strategies
    • 12.12.6. Financials (Based on Availability)
  • 12.13. Smiths Detection Group Ltd (U.K.)
    • 12.13.1. Overview
    • 12.13.2. Products & services
    • 12.13.3. SWOT Analysis
    • 12.13.4. Recent Developments
    • 12.13.5. Strategies
    • 12.13.6. Financials (Based on Availability)
  • 12.14. Parsons Corporation (U.S.)
    • 12.14.1. Overview
    • 12.14.2. Products & services
    • 12.14.3. SWOT Analysis
    • 12.14.4. Recent Developments
    • 12.14.5. Strategies
    • 12.14.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
  • Table 2: Global Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
  • Table 3: Global Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 4: Global Biodefense Market (USD Bn) Forecast, By Region, 2019-2032
  • Table 5: North America Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
  • Table 6: North America Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
  • Table 7: North America Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 8: North America Biodefense Market (USD Bn) Forecast, By Country, 2019-2032
  • Table 9: U.S. Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 10: Canada Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 11: Europe Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
  • Table 12: Europe Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
  • Table 13: Europe Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 14: Europe Biodefense Market (USD Bn) Forecast, By Country, 2019-2032
  • Table 15: U.K. Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 16: Germany Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 17: France Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 18: Russia Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 19: Rest of Europe Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 20: Asia Pacific Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
  • Table 21: Asia Pacific Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
  • Table 22: Asia Pacific Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 23: Asia Pacific Biodefense Market (USD Bn) Forecast, By Country, 2019-2032
  • Table 24: China Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 25: India Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 26: Japan Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 27: South Korea Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 28: Rest of Asia Pacific Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 29: Middle East & Africa Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
  • Table 30: Middle East & Africa Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
  • Table 31: Middle East & Africa Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 32: Middle East & Africa Biodefense Market (USD Bn) Forecast, By Country, 2019-2032
  • Table 33: Iran Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 34: Israel Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 35: Saudi Arabia Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 36: Turkey Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 37: Rest of Middle East & Africa Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 38: Latin America Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
  • Table 39: Latin America Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
  • Table 40: Latin America Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 41: Latin America Biodefense Market (USD Bn) Forecast, By Country, 2019-2032
  • Table 42: Brazil Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 43: Argentina Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 44: Mexico Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 45: Rest of Latin America Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032

List of Figures

  • Figure 1: Global Biodefense Market Revenue Breakdown (USD Billion, %) By Region, 2025 & 2032
  • Figure 2: Global Biodefense Market (%) Breakdown By Technology, 2024 & 2032
  • Figure 3: Global Biodefense Market (USD Bn) Breakdown By Microwave Heating, 2019-2032
  • Figure 4: Global Biodefense Market (USD Bn) Breakdown By UV Light, 2019-2032
  • Figure 5: Global Biodefense Market (USD Bn) Breakdown By Gamma Radiation, 2019-2032
  • Figure 6: Global Biodefense Market (USD Bn) Breakdown By Cold Plasma, 2019-2032
  • Figure 7: Global Biodefense Market (USD Bn) Breakdown By Others, 2019-2032
  • Figure 8: Global Biodefense Market (%) Breakdown By System, 2024 & 2032
  • Figure 9: Global Biodefense Market (USD Bn) Breakdown By Digital Biosurveillance Networks, 2019-2032
  • Figure 10: Global Biodefense Market (USD Bn) Breakdown By Early Warning Systems, 2019-2032
  • Figure 11: Global Biodefense Market (USD Bn) Breakdown By Biohazard Detection Systems, 2019-2032
  • Figure 12: Global Biodefense Market (USD Bn) Breakdown By AI-Assisted Surveillance System, 2019-2032
  • Figure 13: Global Biodefense Market (USD Bn) Breakdown By Biosensors, 2019-2032
  • Figure 14: Global Biodefense Market (USD Bn) Breakdown By Others, 2019-2032
  • Figure 15: Global Biodefense Market (%) Breakdown By End User, 2024 & 2032
  • Figure 16: Global Biodefense Market (USD Bn) Breakdown By Military Forces, 2019-2032
  • Figure 17: Global Biodefense Market (USD Bn) Breakdown By Homeland Security, 2019-2032
  • Figure 18: Global Biodefense Market (USD Bn) Breakdown By Hospitals & Clinics, 2019-2032
  • Figure 19: Global Biodefense Market (USD Bn) Breakdown By Pharmaceutical & Biotech Companies, 2019-2032
  • Figure 20: Global Biodefense Market (USD Bn) Breakdown By Virological Research Institutes, 2019-2032
  • Figure 21: Global Biodefense Market Share (%) By Region, 2024 & 2032
  • Figure 22: North America Biodefense Market Value (USD Bn) By Technology, 2024 & 2032
  • Figure 23: North America Biodefense Market Value Share (%) By Technology, 2024
  • Figure 24: North America Biodefense Market Value (USD Bn) By System, 2024 & 2032
  • Figure 25: North America Biodefense Market Value Share (%) By System, 2024
  • Figure 26: North America Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 27: North America Biodefense Market Value Share (%) By End User, 2024
  • Figure 28: North America Biodefense Market Value (USD Bn) By Country, 2024 & 2032
  • Figure 29: North America Biodefense Value Share (%) By Country, 2024
  • Figure 30: U.S. Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 31: U.S. Biodefense Market Value Share (%) By End User, 2024
  • Figure 32: Canada Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 33: Canada Biodefense Market Value Share (%) By End User, 2024
  • Figure 34: Europe Biodefense Market Value (USD Bn) By Technology, 2024 & 2032
  • Figure 35: Europe Biodefense Market Value Share (%) By Technology, 2024
  • Figure 36: Europe Biodefense Market Value (USD Bn) By System, 2024 & 2032
  • Figure 37: Europe Biodefense Market Value Share (%) By System, 2024
  • Figure 38: Europe Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 39: Europe Biodefense Market Value Share (%) By End User, 2024
  • Figure 40: Europe Biodefense Market Value (USD Bn) By Country, 2024 & 2032
  • Figure 41: Europe Biodefense Value Share (%) By Country, 2024
  • Figure 42: U.K. Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 43: U.K. Biodefense Market Value Share (%) By End User, 2024
  • Figure 44: Germany Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 45: Germany Biodefense Market Value Share (%) By End User, 2024
  • Figure 46: France Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 47: France Biodefense Market Value Share (%) By End User, 2024
  • Figure 48: Russia Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 49: Russia Biodefense Market Value Share (%) By End User, 2024
  • Figure 50: Rest of Europe Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 51: Rest of Europe Biodefense Market Value Share (%) By End User, 2024
  • Figure 52: Asia Pacific Biodefense Market Value (USD Bn) By Technology, 2024 & 2032
  • Figure 53: Asia Pacific Biodefense Market Value Share (%) By Technology, 2024
  • Figure 54: Asia Pacific Biodefense Market Value (USD Bn) By System, 2024 & 2032
  • Figure 55: Asia Pacific Biodefense Market Value Share (%) By System, 2024
  • Figure 56: Asia Pacific Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 57: Asia Pacific Biodefense Market Value Share (%) By End User, 2024
  • Figure 58: Asia Pacific Biodefense Market Value (USD Bn) By Country, 2024 & 2032
  • Figure 59: Asia Pacific Biodefense Value Share (%) By Country, 2024
  • Figure 60: China Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 61: China Biodefense Market Value Share (%) By End User, 2024
  • Figure 62: India Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 63: India Biodefense Market Value Share (%) By End User, 2024
  • Figure 64: Japan Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 65: Japan Biodefense Market Value Share (%) By End User, 2024
  • Figure 66: South Korea Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 67: South Korea Biodefense Market Value Share (%) By End User, 2024
  • Figure 68: Rest of Asia Pacific Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 69: Rest of Asia Pacific Biodefense Market Value Share (%) By End User, 2024
  • Figure 70: Middle East & Africa Biodefense Market Value (USD Bn) By Technology, 2024 & 2032
  • Figure 71: Middle East & Africa Biodefense Market Value Share (%) By Technology, 2024
  • Figure 72: Middle East & Africa Biodefense Market Value (USD Bn) By System, 2024 & 2032
  • Figure 73: Middle East & Africa Biodefense Market Value Share (%) By System, 2024
  • Figure 74: Middle East & Africa Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 75: Middle East & Africa Biodefense Market Value Share (%) By End User, 2024
  • Figure 76: Middle East & Africa Biodefense Market Value (USD Bn) By Country, 2024 & 2032
  • Figure 77: Middle East & Africa Biodefense Value Share (%) By Country, 2024
  • Figure 78: Iran Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 79: Iran Biodefense Market Value Share (%) By End User, 2024
  • Figure 80: Israel Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 81: Israel Biodefense Market Value Share (%) By End User, 2024
  • Figure 82: Saudi Arabia Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 83: Saudi Arabia Biodefense Market Value Share (%) By End User, 2024
  • Figure 84: Turkey Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 85: Turkey Biodefense Market Value Share (%) By End User, 2024
  • Figure 86: Rest of Middle East & Africa Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 87: Rest of Middle East & Africa Biodefense Market Value Share (%) By End User, 2024
  • Figure 88: Latin America Biodefense Market Value (USD Bn) By Technology, 2024 & 2032
  • Figure 89: Latin America Biodefense Market Value Share (%) By Technology, 2024
  • Figure 90: Latin America Biodefense Market Value (USD Bn) By System, 2024 & 2032
  • Figure 91: Latin America Biodefense Market Value Share (%) By System, 2024
  • Figure 92: Latin America Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 93: Latin America Biodefense Market Value Share (%) By End User, 2024
  • Figure 94: Latin America Biodefense Market Value (USD Bn) By Country, 2024 & 2032
  • Figure 95: Latin America Biodefense Value Share (%) By Country, 2024
  • Figure 96: Brazil Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 97: Brazil Biodefense Market Value Share (%) By End User, 2024
  • Figure 98: Argentina Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 99: Argentina Biodefense Market Value Share (%) By End User, 2024
  • Figure 100: Mexico Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 101: Mexico Biodefense Market Value Share (%) By End User, 2024
  • Figure 102: Rest of Latin America Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 103: Rest of Latin America Biodefense Market Value Share (%) By End User, 2024
  • Figure 104: Global Biodefense Market Rank Analysis, By Key Players, 2024